Tradestie Institutional Equity Comparison Engine
HHS vs TTI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HHS Overall Edge
HHS Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Harte Hanks, Inc. (HHS) driven by superior Valuation, Momentum & Technical while TTI counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, HHS trades at 14.3x Forward P/E with -3.2% operating margin (-1.7% YoY revenue) versus TTI at 20.7x Forward P/E and 7.4% operating margin (+9.6% YoY). In options structure, HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TTI sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HHS
HHS 14.3x vs TTI 20.7x Fwd P/E
Growth & Margin Winner
TTI
Op Margin -3.2% vs 7.4% ยท YoY -1.7% vs +9.6%
Momentum & Technical Winner
HHS
1Y +9.1% vs -17.4% ยท 52W Pos 69% vs 17%
Options & Structure Winner
TTI
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
HHS
US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.85
-3.99% 1D
Market Cap
$29.9M
1M Return
-10.26%
1Y Return
+9.07%
Forward P/E
14.3x
Unified AI Score
61.8 / 100
BUY
Tech 76.0
Fund 61.0
Flow 50.0
Mom 54.0
TTI
NYSE
TETRA Technologies, Inc.
Crude Petroleum & Natural Gas
$6.20
-2.97% 1D
Market Cap
$948.5M
1M Return
+16.54%
1Y Return
-17.44%
Forward P/E
20.7x
Unified AI Score
35.2 / 100
SELL
Tech 8.0
Fund 33.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HHS +9.07%
TTI -17.44%
Spread: +52.53 pp (HHS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HHS TTM Op. Margin: -3.2%
TTI TTM Op. Margin: 7.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs TTI. Trailing 12-month operating profitability (HHS -3.2% vs TTI 7.4%) and valuation multiples (HHS 14.3x vs TTI 20.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HHS | TTI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9M | $948.5M | Larger Scale | TTI |
| Trailing P/E Ratio Valuation | 14.3x | 91.3x | Lower Multiple | HHS |
| Forward P/E Ratio Valuation | 14.3x | 20.7x | Lower Multiple | HHS |
| Revenue Growth (YoY) Growth | -1.7% | +9.6% | Higher Growth | TTI |
| Operating Margin (TTM) Profitability | -3.2% | 7.4% | Higher Margin | TTI |
| Net Profit Margin Profitability | -3.7% | 1.4% | Higher Margin | TTI |
| Return on Equity (ROE) Capital Efficiency | -30.4% | 2.9% | Higher ROE | TTI |
| 52-Week Range Position Momentum | 69% ($2โ$5) | 17% ($5โ$13) | Stronger Trend | HHS |
| Beta / 30D Volatility Risk Regime | 0.49ฮฒ ยท 46% Vol | 1.45ฮฒ ยท 61% Vol | Lower Realized Risk | HHS |
| Unified Institutional Score Composite Signal | 61.8 / 100 (BUY) | 35.2 / 100 (SELL) | Higher Composite | HHS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HHS vs TTI Buy Guide
HHS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TTI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HHS nor TTI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.